High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland

References

• Liitsola K, Ristola M, Holmstrom P, Salminen M, Brum- mer-Korvenkontio H, Simola S, et al. An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population. AIDS 2000;14: 2613–5.
   Google Scholar
• Wasi C, Herring B, Raktham S, Vanichseni S, Mastro TD, Young NL, et al. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide- binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS 1995;9:843–9.
   PubMedGoogle Scholar
• Bobkov A, Kazennova E, Selimova L, Ladnaya N, Kravchenko A, Foley B, et al. HIV type 1 gag D/env G recombinants in Russia. AIDS Res Hum Retroviruses 1998; 14:1597–9.
   PubMedGoogle Scholar
• Liitsola K, Tashkinova I, Laukkanen T, Korovina G, Smolskaja T, Momot O, et al. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907–19.
   PubMed Web of Science ®Google Scholar
• Kuiken CL, Goudsmit J. Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe. AIDS Res Hum Retroviruses 1994;10:319–20.
   PubMedGoogle Scholar
• Galai N, Kalinkovich A, Burstein R, Vlahov D, Bentwich Z. African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel. Lancet 1997;349: 180–1.
   Google Scholar
• Del Amo J, Petruckevitch A, Phillips A, Johnson AM, Stephenson J, Desmond N, et al. Disease progression and survival in HIV-1-infected Africans in London. AIDS 1998;12:1203–9.
   PubMed Web of Science ®Google Scholar
• Alaeus A, Lidman K, Bjorkman A, Giesecke J, Albert J. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS 1999;13: 901–7.
   Google Scholar
• Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in western and west-central Africa: a 4-y prospective multicentre study. J Infect Dis 2002;186:486–92.
   PubMedGoogle Scholar
• Neilson JR, John GC, Carr JK, Lewis P, Kreiss JK, Jackson S, et al. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999;73:4393–403.
   PubMed Web of Science ®Google Scholar
• Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002;185:1244–50.
   PubMed Web of Science ®Google Scholar
• Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999;179:68–73.
   PubMed Web of Science ®Google Scholar
• Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, Rutebemberwa A, et al. Relationship between HIV-1 env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 2001;15:293–9.
   PubMedGoogle Scholar
• Hu DJ, Vanichseni S, Mastro TD, Raktham S, Young NL, Mock PA, et al. Viral load differences in early infection with 2 HIV-1 subtypes. AIDS 2001;15:683–91.
   PubMedGoogle Scholar
• Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E, et al. Primary HIV-1 subtype C infection in Ethiopia. J Acquir Immune Defic Syndr 2002;30:463–70.
   PubMedGoogle Scholar
• Op de Coul EL, Prins M, Cornelissen M, van der Schoot A, Boufassa F, Brettle RP, et al. European and Italian Seroconverter Studies. Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997. AIDS 2001;15: 257–66.
   Google Scholar
• van den Hoek JA, Coutinho RA, van Haastrecht HJ, van Zadelhoff AW, Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988;2:55–60.
   PubMed Web of Science ®Google Scholar
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41: 1–19.
   Google Scholar
• Hughes JP. Mixed effects models with censored data with application to HIV RNA levels. Biometrics 1999;55:625–9.
   PubMed Web of Science ®Google Scholar
• Krol A, Flynn C, Vlahov D, Miedema F, Coutinho RA, van Ameijden EJ. New evidence to reconcile in vitro and epidemiological data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users. Drug Alcohol Depend 1999;54: 145–54.
   Google Scholar
• Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. Rakai Project Team. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357: 1149–53.
   Google Scholar
• Tovanabutra S, Robison V, Wongtrakul J, Sennum S, Suriyanon V, Kingkeow D, et al. Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. J Acquir Immune Defic Syndr 2002;29:275–83.
   PubMed Web of Science ®Google Scholar
• Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996;335:1621–9.
   PubMed Web of Science ®Google Scholar
• Shaffer N, Roongpisuthipong A, Siriwasin W, Chotpitaya-sunondh T, Chearskul S, Young NL, et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis 1999;179: 590–9.
   Google Scholar
• Liitsola K, Holm K, Bobkov A, Pokrovsky V, Smolskaya T, Leinikki P, et al. An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network. AIDS Res Hum Retroviruses 2000;16:1047–53.
   PubMedGoogle Scholar
• Zetterberg V, Ustina V, Liitsola K, Zilmer K, Kalikova N, Sevastianova K, et al. Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. AIDS Res Hum Retroviruses 2004;20:1148–56.
   PubMed Web of Science ®Google Scholar
• Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167–70.
   PubMed Web of Science ®Google Scholar
• Margolick JB, Farzadegan H, Hoover DR, Saah AJ. Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T-lymphocyte subsets, and stage of infection in homosexual men. J Infect Dis 1996;173:468–71.
   PubMedGoogle Scholar
• O’Brien TR, Blattner WA, Waters D, Eyster E, Hilgartner MW, Cohen AR, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicentre Haemophilia Cohort Study. JAMA 1996;276: 105–10.
   Google Scholar
• Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viraemia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicentre AIDS Cohort Study. J Infect Dis 2000;181: 872–80.
   PubMed Web of Science ®Google Scholar
• Michael NL, Herman SA, Kwok S, Dreyer K, Wang J, Christopherson C, et al. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol 1999;37:2557–63.
   PubMedGoogle Scholar
• Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999;15:133–42.
   PubMed Web of Science ®Google Scholar
• Vandamme AM, Schmit JC, van Dooren S, van Laethem K, Gobbers E, Kok W, et al. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13: 127–39.
   Google Scholar